Genprex, Inc. Recorded Big Gain

Tue, Nov 12, 2024 at 07:33 PM

Genprex, Inc. (GNPX:NASDAQ) shot up at $2.09, a gain of 56%. On Tue, Nov 12, 2024, GNPX:NASDAQ hit a New 2-Week Intraday High of $2.35. The stock appeared on our News Catalysts scanner on Tue, Nov 05, 2024 at 11:15 AM in the 'PATNERSHIP' category. From Tue, Oct 29, 2024, the stock recorded 30.00% Up Days and 27.27% Green Days

The stock spiked on Fri, Nov 01, 2024 at $2.59 with a volume of 4M+.

About Genprex, Inc. (GNPX:NASDAQ)

Genprex Inc is a clinical stage gene therapy company. It develops therapies that carry cancer-fighting genes. Its initial product candidate is Oncoprex.

Top 10 Gainers:

BTC Digital Ltd. (BTCT:NASDAQ), 316.67%
Nano Labs Ltd (NA:NASDAQ), 134.04%
Next Technology Holding Inc. (NXTT:NASDAQ), 76.52%
Mullen Automotive Inc. (MULN:NASDAQ), 74.27%
Genius Group Limited (GNS:NYSEMKT), 66.4%
Agrify Corporation (AGFY:NASDAQ), 58.59%
Genprex, Inc. (GNPX:NASDAQ), 55.97%
Kairos Pharma Ltd. (KAPA:NYSEMKT), 51.05%
MediciNova, Inc. (MNOV:NASDAQ), 49.02%
Taysha Gene Therapies Inc. (TSHA:NASDAQ), 46.63%